Skip to content

Carotid Plaque Imaging in Acute Stroke

Carotid Plaque Imaging in Acute Stroke

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01284933
Acronym
CAPIAS
Enrollment
234
Registered
2011-01-27
Start date
2011-02-28
Completion date
2021-07-31
Last updated
2021-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Attack, Transient, Stroke

Keywords

Stroke, Ischemic Attack, Transient, Magnetic Resonance Imaging, Carotid Arteries, Carotid Artery Plaque, Atherosclerosis

Brief summary

The purpose of this study is to determine the frequency, characteristics, and consequences of vulnerable carotid artery plaques ipsilateral to an acute ischemic stroke or TIA in the territory of the internal carotid artery.

Detailed description

Even with extensive diagnostic workup the underlying etiology remains unidentified in about 25% of patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA). Non-invasive high-resolution magnetic resonance imaging (HR-MRI) of the carotid artery allows detecting vulnerable plaques (VP) and quantifying single plaque components. The hypotheses behind this study are that i) a substantial proportion of cases of AIS and TIA within the anterior circulation and no identified cause (cryptogenic AIS or TIA) are caused by VP in the carotid artery; ii) that these patients are at a high risk of developing a recurrent stroke, TIA, or clinically silent lesions detectable by brain MRI; and iii) that VP in the carotid artery are associated with specific infarct patterns as detected by diffusion-weighted MR imaging. Finally, the investigators will search for biomarkers associated with vulnerable carotid artery plaques. Motivating this study are the following considerations: i) data on the frequency and characteristics of VP in patients with cryptogenic AIS or TIA will provide valuable insights into stroke mechanisms; ii) depending on the results this study may have implications for diagnostic decision making and provide the basis for the planning of targeted interventional studies.

Interventions

None listed

Sponsors

Technical University of Munich
CollaboratorOTHER
Ludwig-Maximilians - University of Munich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 49 years old * Acute ischemic stroke or transient ischemic attack (TIA) * Neurological symptoms compatible with a stroke or TIA in the anterior circulation (territory of the internal carotid artery) * Onset of symptoms within the last 7 days * 1 or more acute ischemic lesion(s) visible on MR diffusion-weighted imaging (DWI) in the territory of a single internal carotid artery * Presence of carotid artery plaques in the ipsilateral or contralateral carotid artery as defined by ultrasound (criteria: plaque thickness at least 2mm; located within 1cm proximal or distal to the carotid bifurcation) * Written informed consent

Exclusion criteria

* Primary referral to an outside hospital (to avoid recruitment bias) * DWI positive lesions outside the territory of a single internal carotid artery * Carotid artery stenosis \> 69% (North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria) ipsilateral to the stroke or TIA as defined by ultrasound (systolic peak flow velocity ≥ 300 cm/s) * Standard contra-indications for MRI * Documented allergy to MRI contrast media * History of radiation to the neck area * Renal clearance \< 30 ml/minute * Creatinine levels \> 2 times the upper limit of the standard range of the respective laboratory within the last 30 days prior to MRI * Surgical procedure within 24 hours preceding the MRI

Design outcomes

Primary

MeasureTime frameDescription
Frequency and characteristics of vulnerable plaques (VP) in the carotid artery ipsilateral to an acute ischemic stroke (AIS) or TIA in the territory of the carotid artery in patients with a cryptogenic strokeBaselineFor the primary outcome, definition of a VP will be based on non-invasive high-resolution magnetic resonance imaging (MRI). We will classify plaques according to the American Heart Association - Lesion Type (AHA-LT) classification (Cai et al. Circulation 2002; Saam et al.). Comparisons will include: * a comparison of the frequency and characteristics of VP ipsilateral vs. contralateral to the AIS or TIA * a comparison of the frequency and characteristics of ipsilateral VP in patients with cryptogenic stroke as compared to patients with cardioembolic stroke or small vessel stroke

Secondary

MeasureTime frameDescription
Pattern of acute ischemic lesions on brain MRI associated with VP in the carotid arteryBaselineThe pattern of acute ischemic lesions on brain MRI associated with VP in the carotid artery will be analyzed.
Recurrence rates of AIS or TIA in patients with VP in the carotid artery12, 24, 36 MonthsThe recurrence rates of acute ischemic strokes or transient ischemic attacks will be evaluated at follow-up after 12, 24 and 36 months.
Rate of new ischemic lesions on FLAIR MRI at 12 month follow-up in patients with VP in the carotid artery12 MonthsThe rate of new ischemic lesions on FLAIR MRI will be evaluated at follow-up after 12 months.
Association between VP in the carotid artery and atherosclerotic plaques in the aortic arch as determined by transoesophageal ultrasoundBaselineThe association between VP in the carotid artery and atherosclerotic plaques in the aortic arch as determined by transoesophageal ultrasound will be evaluated in patients with transoesophageal ultrasound.
Biomarkers associated with vulnerable carotid artery plaquesBaselineBiomarkers probably associated with vulnerable carotid artery plaques will be analyzed.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026